InSphero AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:InSphero AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10437
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture platforms and methods enable production of assay-ready 3D InSight microtissues derived from liver, pancreas, tumor, heart, brain and skin. InSphero offers services such as in vitro toxicology, diabetes and nash drug discovery, and oncology drug discovery. The company’s models and research services identifies drugs and toxic liabilities at early development stages. It operates in Switzerland, the US and Germany. InSphero is headquartered in Schlieren, Switzerland.

InSphero AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InSphero AG, Medical Equipment, Deal Details 10
Venture Financing 10
InSphero Raises USD10 Million in Financing 10
InSphero Raises US$2.1 Million In Series B Financing 11
Partnerships 12
InSphero to Enter into Licensing Agreement with Charles River Labs 12
InSphero Enters into Partnership with ALPCO 13
InSphero Enters into Licensing Agreement with National Center for Advancing Translational Sciences 14
InSphero Enters into Agreement with Pfizer 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 17
Acquisition 18
Redalpine Venture Partners Sells Interest in InSphero 18
InSphero AG – Key Competitors 19
InSphero AG – Key Employees 20
InSphero AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Jun 11, 2018: InSphero Partners with ALPCO to Advance Diabetes Research 22
Product News 23
Apr 03, 2017: Novel 3D Cell-based Assays Accelerate Discovery for Immuno-oncology/CAR-T Therapies 23
Feb 02, 2017: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
InSphero AG, Medical Equipment, Key Facts 2
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Deals By Market, 2012 to YTD 2018 8
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InSphero Raises USD10 Million in Financing 10
InSphero Raises US$2.1 Million In Series B Financing 11
InSphero to Enter into Licensing Agreement with Charles River Labs 12
InSphero Enters into Partnership with ALPCO 13
InSphero Enters into Licensing Agreement with National Center for Advancing Translational Sciences 14
InSphero Enters into Agreement with Pfizer 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 17
Redalpine Venture Partners Sells Interest in InSphero 18
InSphero AG, Key Competitors 19
InSphero AG, Key Employees 20
InSphero AG, Subsidiaries 21

List of Figures
InSphero AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[InSphero AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy …
  • MeVis Medical Solutions AG (M3V)-医療機器分野:企業M&A・提携分析
    Summary MeVis Medical Solutions AG (MMS AG) is a medical technology company. It develops and offers medical imaging solutions for digital computer-aided medical imaging. The software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate …
  • Erin Energy Corp (ERN):企業の財務・戦略的SWOT分析
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • HealthCare Global Enterprises Ltd (HCG):企業の財務・戦略的SWOT分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Tan Chong Motor Holdings Berhad (TCHONG):企業の財務・戦略的SWOT分析
    Tan Chong Motor Holdings Berhad (TCHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • China Southern Power Grid Co Ltd:電力:M&Aディール及び事業提携情報
    Summary China Southern Power Grid Co Ltd (CSG) is a power company that invests in construction, operations and management of the power grids. The company concentrates on developing regional power network, managing power dispatching and transaction center, administering regional power market, and dis …
  • McRae Industries, Inc.:企業の戦略・SWOT・財務情報
    McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Turkiye Petrol Rafinerileri AS (TUPRS):企業の財務・戦略的SWOT分析
    Turkiye Petrol Rafinerileri AS (TUPRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Epsilon Energy Ltd (EPS):石油・ガス:M&Aディール及び事業提携情報
    Summary Epsilon Energy Ltd (Epsilon) is an oil and gas company that provides exploration, exploitation and development of oil and gas reserves. The company provides projects such as Marcellus shale in northeast Pennsylvania, Bakken Shale and Midale Dolomite in Saskatchewan, among others. It operates …
  • Forma Therapeutics Inc:企業のM&A・事業提携・投資動向
    Forma Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Forma Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Parkland Fuel Corp (PKI):企業の財務・戦略的SWOT分析
    Parkland Fuel Corp (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tractebel Engineering S.A.:企業の戦略的SWOT分析
    Tractebel Engineering S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nordion (Canada) Inc:企業の戦略的SWOT分析
    Nordion (Canada) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Banco Santander-Chile:企業の戦略・SWOT・財務分析
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆